Dolasetron (Anzemet)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 17:26, 3 November 2014 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

5-HT3 antagonist

Retrieved from "https://hemonc.org/w/index.php?title=Dolasetron_(Anzemet)&oldid=5379"